# Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

> **NCT00967616** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 100 (actual)

## Conditions studied

- Colorectal Cancer
- Neoplasms, Colorectal

## Interventions

- **DRUG:** CS7017
- **DRUG:** irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)

## Key facts

- **NCT ID:** NCT00967616
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967616, "Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00967616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*